Skip to main content

Arthrex Knee Implant Suit Moves Forward in Pa. Federal Court

Arthrex Knee Implant Suit Moves Forward in Pa. Federal Court

Arthrex Knee Implant Suit Moves Forward in Pa. Federal Court

Introduction

In an order issued on February 27, Judge A. Richard Caputo of the U.S. District Court for the Middle District of Pennsylvania refused to toss a lawsuit involving complaints against Arthrex Inc.'s iBalance knee implant, ruling that the claims filed were timely because the limitations period did not begin until the plaintiff's second knee implant failed.

The lawsuit involved allegations by a couple that the iBalance knee devices implanted in the woman's knee twice were defective. The Pennsylvania court found that a question of fact existed whether the negligence claims were preempted by federal law. Similar complaints regarding knee implant failure have been filed against other manufacturers like Zimmer  Inc., Stryker Corporation, and DePuy Orthopedics. Recently, plaintiffs involved in the Zimmer NexGen knee implant litigation agreed to be part of a global settlement program to resolve most of the lawsuits pending in the state and federal courts.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!